Description: Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Latin America. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and sexual improvement, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, and infant nutrition. The company was incorporated in 1996 and is based in Mexico City, Mexico.
Home Page: www.genommalab.com
Av. Antonio Dovalí Jaime, number 70
Mexico City,
DF
01210
Mexico
Phone:
52 55 5081 0000
Officers
| Name | Title |
|---|---|
| Lic. Rodrigo Alonso Herrera Aspra | Founder & Chairman of the Board |
| Mr. Juan Marco Sparvieri | Chief Executive Officer |
| Engineer Antonio Zamora Galland | Executive VP of Finance & Administration and CFO |
| Ms. Christianne Ibáñez Garcia | Head of Investor Relations |
| Mr. Alejandro Bastón Patiño | EVP of Institutional Relations, Media, HR & Sustainability |
| Mr. Efraan Tapia Cardova | Secretary |
| Daniel Suarez Neria | Investor Relations Officer |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 13.459 |
|---|---|
| Trailing PE: | 24.2 |
| Price-to-Book MRQ: | 2.2016 |
| Price-to-Sales TTM: | 0.0676 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1633 |